GnRH agonists and antagonists in assisted reproduction: pregnancy rate. (Q53006478)

10 May 2018

title

GnRH agonists and antagonists in assisted reproduction: pregnancy rate. (English)

1 reference

10 May 2018

author name string

Engel JB

1

1 reference

10 May 2018

Griesinger G

2

1 reference

10 May 2018

Schultze-Mosgau A

3

1 reference

10 May 2018

Felberbaum R

4

1 reference

10 May 2018

Diedrich K

5

1 reference

10 May 2018

publication date

1 July 2006

1 reference

10 May 2018

Reproductive BioMedicine Online

published in

1 reference

10 May 2018

volume

13

1 reference

10 May 2018

issue

1

1 reference

10 May 2018

page(s)

84-87

1 reference

10 May 2018

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

cites work

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

GnRH antagonist in assisted reproduction: a Cochrane review

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

The role of LHRH agonists and antagonists.

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

Extrapituitary effects of GnRH antagonists in assisted reproduction: a review

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

No influence of body weight on pregnancy rate in patients treated with cetrorelix according to the single- and multiple-dose protocols

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'?

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

Gonadotrophin-releasing hormone antagonists: will they replace the agonists?

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

The place of gonadotrophin-releasing hormone antagonists in reproductive medicine.

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

Safety aspects of gonadotrophin-releasing hormone antagonists in ovarian stimulation procedures: ovarian hyperstimulation syndrome and health of children born.

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

1 reference

https://api.crossref.org/works/10.1016/S1472-6483(10)62019-6

7 January 2021

10.1016/S1472-6483(10)62019-6

Identifiers

DOI

1 reference

10 May 2018

1 reference

10 May 2018